JORVEZA

avir pharma inc.🇨🇦 Health Canada

Approval Id: 2c5e39b79c835102
Drug Approval Canada Name: JORVEZA
Product Name: JORVEZA
Status: Marketed
Status Date: 2021-10-19
Original Market Date: 2021-10-19
Din: 02513854
Drug Class: Human
Dosage Form: Tablet (Orally Disintegrating)
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 68:04.00
Atc Original: A07EA06 BUDESONIDE
Atc Name: a 07 ea 06
Aig Number: 0116807011
Company Name: avir pharma inc.
Company Address: 660 Boulevard Industriel, Blainville, Quebec, Canada, J7C 3V4

BUDESONIDE

0.5 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

2c5e39b79c835102

Type

Standard